Conduit Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,076,964 | $244,004 | $604,336 | $535,675 |
Gross Profit | 660,738 | 244,004 | 226,806 | 201,596 |
EBITDA | 69,179 | -6,146 | -5,264 | -2,955 |
EBIT | -5,811 | -29,942 | ||
Net Income | 58,384 | -6,461 | -5,383 | -3,571 |
Net Change In Cash | 1,076,964 | 244,004 | 604,336 | 535,675 |
Free Cash Flow | 253,146 | -2,040 | -1,523 | -26,607 |
Cash | 370,302 | 71 | 219 | 1,844 |
Basic Shares | 41,299 | 43,577 | 36,925 | 36,914 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,460,979 | $0 | $0 | $0 |
Gross Profit | 922,222 | |||
EBITDA | 266,460 | -324 | -1,433 | -4 |
EBIT | -491 | -3,160 | -488 | |
Net Income | 198,433 | -535 | -4,887 | -3,657 |
Net Change In Cash | 2,460,979 | 0 | 0 | 0 |
Free Cash Flow | 222,976 | -7,725 | -2,266 | -2,151 |
Cash | 370,302 | 4,228 | 345 | 48 |
Basic Shares | 41,299 | 33,946 | 8,642 | 8,642 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$7.41 |
2024-06-30 | -$7.28 |
2024-03-31 | -$4.83 |
2023-12-31 | -$1.52 |
